comparison of two high-power in the upper trapezius muscle

Investigation of the effect and comparison of two high-power laser treatment protocols for the improvement of clinical symptoms in patients with painful points in the upper trapezius muscle: a randomized clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230324057771N1

Enrollment

Registered

2023-04-24

Start date

2023-05-05

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain in the upper trapezius muscle.

Interventions

Intervention 1: Intervention group: In addition to standard and routine treatment. He receives 4 sessions (two sessions per week) of high power laser (wavelength 910 nm and power of one watt as pulse

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age more than 18 years Visual analog scale greater than 5 points Duration of pain more than a month Patient satisfaction to participate in the study

Exclusion criteria

Exclusion criteria: A history of cervical spine fracture and spine-related problems Neck surgery, myelopathy or radiculopathy of the neck Patients with perceptual disorders and pain diagnosis Patients with myopathy and polyneuropathy Mental illnesses or cognitive disorders Receiving narcotics and coronet orally or intravenously pregnancy Blood clotting problem

Design outcomes

Primary

Measure	Time frame
Pain reduction in the patient. Timepoint: before the treatment, immediately after the treatment, one month and three months after the treatment in each of the three groups. Method of measurement: VAS pain scale.;Reducing disability in the patient. Timepoint: before the treatment, immediately after the treatment, one month and three months after the treatment in each of the three groups. Method of measurement: Shoulder Pain and Disability Index (SPADI) scale.	—

Measure

Time frame

Pain reduction in the patient. Timepoint: before the treatment, immediately after the treatment, one month and three months after the treatment in each of the three groups. Method of measurement: VAS pain scale.;Reducing disability in the patient. Timepoint: before the treatment, immediately after the treatment, one month and three months after the treatment in each of the three groups. Method of measurement: Shoulder Pain and Disability Index (SPADI) scale.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBabak Vahdatpour

Esfahan University of Medical Sciences

vahdatpour@med.mui.ac.ir+98 31 3112 2020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026